Oxford Immunotec Global PLC Ordinary Shares
OXFD
OXFD was delisted on the 5th of March, 2021.
65 hedge funds and large institutions have $209M invested in Oxford Immunotec Global PLC Ordinary Shares in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 26 increasing their positions, 20 reducing their positions, and 3 closing their positions.
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
30% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 20
5% more funds holding
Funds holding: 62 → 65 (+3)
16% less capital invested
Capital invested by funds: $249M → $209M (-$39.7M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Polar Capital
London,
United Kingdom
|
+$3.21M |
| 2 |
GPGA
Grandeur Peak Global Advisors
Salt Lake City,
Utah
|
+$1.62M |
| 3 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$667K |
| 4 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
+$528K |
| 5 |
BC
Birchview Capital
Burlington,
Vermont
|
+$309K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$2.08M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.47M |
| 3 |
TAM
Tiverton Asset Management
Wilimington,
Delaware
|
-$1.35M |
| 4 |
FA
Friess Associates
Greenville,
Delaware
|
-$651K |
| 5 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
-$619K |
OXFD Hedge Fund Activity: Q4 2015 in Review
65 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q4 2015, worth a combined $209M — down 16% from $249M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new OXFD positions and 3 closed out — a net gain of 3 holders — while 26 added to existing stakes and 20 trimmed.
The largest buyer was Polar Capital, adding an estimated $3.21M. The largest seller was Redmile Group, cutting an estimated $2.08M.
- 65 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q4 2015, up from 62 in Q3 2015.
- Funds reported $209M of Oxford Immunotec Global PLC Ordinary Shares stock for Q4 2015, down 16% quarter-over-quarter.
- 6 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q4 2015 and 3 closed out, a net change of +3 holders.
- The largest Oxford Immunotec Global PLC Ordinary Shares buyer in Q4 2015 was Polar Capital, an estimated $3.21M added.
- The largest Oxford Immunotec Global PLC Ordinary Shares seller in Q4 2015 was Redmile Group, an estimated $2.08M sold.
Based on aggregated 13F filings for Q4 2015.